PCMC
PCRX icon

Planning Capital Management Corporation’s Pacira BioSciences PCRX Stock Holding History

Planning Capital Management Corporation’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.12K Hold
340
– – ﹤0.01% 509
2024
Q2 		$9.73K Hold
340
– – 0.01% 410
2024
Q1 		$9.94K Buy
+340
New +$10.4K 0.01% 425

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Planning Capital Management Corporation's PCRX Position: Q3 2024 in Review

Planning Capital Management Corporation held its Pacira BioSciences (PCRX) position steady in Q3 2024 at 340 shares worth $5.12K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Planning Capital Management Corporation first reported a position in PCRX in Q1 2024 and has held it in 3 quarters since. The position peaked at $9.94K in Q1 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Planning Capital Management Corporation held 340 shares of Pacira BioSciences worth $5.12K as of Q3 2024.
  • Planning Capital Management Corporation left its Pacira BioSciences share count unchanged in Q3 2024.
  • Pacira BioSciences made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #509 holding.
  • Planning Capital Management Corporation first reported a position in Pacira BioSciences in Q1 2024 and has held it in 3 quarters since.
  • Planning Capital Management Corporation's Pacira BioSciences position peaked at $9.94K in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.